Stericycle INC: insider trades · United States · SEC (Form 4)

About Stericycle INC

Stericycle Inc. was a U.S.-based business services company focused on regulated waste and compliance solutions, and it was historically listed in the United States on the NASDAQ under ticker SRCL. Founded in 1989, the company built its reputation over more than three decades as a specialist in medical waste management, secure information destruction, and compliance-support services for healthcare and commercial customers. Its headquarters were in Bannockburn, Illinois, in the greater Chicago area, reflecting its long-standing roots in the highly regulated environmental and healthcare-services segment. A key point for investors is that Stericycle is no longer an independent listed company: WM completed its acquisition in late 2024, and SRCL ceased trading on NASDAQ after the deal closed. Stericycle’s core business centered on the collection, transport, treatment, and disposal of regulated medical waste, a service category that demands strict chain-of-custody controls, specialized processing infrastructure, and continuous adherence to environmental and public-health rules. Beyond medical waste, the company offered secure information destruction services, helping customers dispose of paper and other media containing sensitive or confidential data. It also provided compliance-oriented solutions, including support around HIPAA and OSHA requirements, as well as services related to pharmaceutical and hazardous waste streams in certain customer segments. This integrated model positioned Stericycle as a one-partner solution for hospitals, physician offices, laboratories, dental practices, and commercial organizations that needed both operational reliability and regulatory assurance. From a competitive standpoint, Stericycle’s value proposition rested on scale, recurring service relationships, operational expertise, and the complexity barrier of the markets it served. The company operated in a fragmented industry where trust, compliance credentials, and route density matter materially. That made it relatively well positioned versus smaller local operators, especially for multi-site customers and national healthcare systems. Stericycle’s footprint extended across North America and, according to company disclosures, parts of Europe and other international markets. Recent developments have been dominated by the WM transaction, which is the most important corporate event in the company’s recent history. Prior to the acquisition, Stericycle had also continued to expand and refresh its operating platform, including investments in medical waste processing capacity and newer product offerings such as improved waste containers. For investors analyzing SRCL-related SEC Form 4 insider transactions, the key takeaway is that the stock’s independent public-market story is now in the past, and the name should be viewed primarily through its legacy operating profile and the final pre-acquisition filings rather than as a currently traded standalone equity.